Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 1, 1997, Pages 174-188

  Rush, Craig R ^a,b   Madakasira, Sudhakar ^a   Goldman, Nancy H ^a   Woolverton, William L ^a,b   Rowlett, James K ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; PENTOBARBITAL; TRIAZOLAM; ZOLPIDEM TARTRATE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPNOSIS; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEDATION; STIMULUS RESPONSE; TASK PERFORMANCE;

ADULT; CAFFEINE; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PENTOBARBITAL; PYRIDINES; TRIAZOLAM;

EID: 0030893307     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (88)

1. ALTMAN, J. L., ALBERT, J. M., MILSTEIN, S. L. AND GREENDERG, I.: Drugs as discriminative stimuli in humans. In Discriminative Stimulus Properties of Drugs, ed. by H. Lai, pp. 187-206, Plenum Press. New York, NY, 1977.
2. ARBILLA, S., DEPOORTERE, H., GEORGE, P. AND LANGE, S. Z.: Pharmacological profile of the imidazopyridine zolpidem at benzodiazepine receptors and electrocorticogram in rats. Arch. Pharmacol. 330: 248-251, 1985.
3. ATOR, N. A. AND GRIFFITHS, R. R.: Lorazepam and pentobarbital drug discrimination in baboons: Cross-drug generalization and interaction with Ro 15-1788. J. Pharmacol. Exp. Ther. 226: 776-782, 1983.
4. ATOR, N. A. AND GRIFFITHS, R. R.: Lorazepam and pentobarbital discrimination: Interactions with CGS 8216 and caffeine. Eur. J. Pharmacol. 107: 169-181, 1985.
5. ATOR, N. A. AND GRIFFITHS, R. R.: Asymmetrical cross-generalization with lorazepam and pentobarbital training conditions. Drug, Dev. Res. 16: 355-364, 1989.
6. BALSTER, R. L. AND MOSER, V. C.: Pentobarbital discrimination in the mouse. Alcohol Drug Res. 7: 233-242, 1987.
7. BARRY, H. I. AND KRIMMER, E. C.: Differential stimulus attributes of chlordiaz - epoxide and pentobarbital. Neuropharmacology 18: 991-998, 1979.
8. 1) subtype. J. Pharmacol. Exp. Ther. 245: 1033-1041, 1988.
9. BERLIN I., WAROT, D., HERGUETA, T., MOLINIER, P., BAGOT, C. AND PUECH, A. J.: Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects. J. Clin. Psychopharmacol. 13: 100-106, 1993.
10. BICKEL, W. K., BIGELOW, G. E., PRESTON, K. L. AND LIEBSON, I. A.: Opioid drug discrimination in humans: Stability, specificity and relation to self-reported drug effect. J. Pharmacol. Exp. Ther. 251: 1053-1063, 1989.
11. BICKEL, W. K., OLIVETO, A. H., KAMIEN, J. B., HEGGINS, S. T. AND HUGHES, J. R.: A novel-response procedure enhances the selectivity and sensitivity of a triazolam discrimination in humans. J. Pharmacol. Exp. Ther. 264: 360-367, 1993.
12. BIGGIO, G., CONCAS, A., CORDA, M. AND SERRA, M.: Enhancement of GABAergic transmission by zolpidem, an imidazopyridine with preferential affinity for type I benzodiazepine receptors. Eur. J. Pharmacol. 161: 173-180, 1989.
13. BYRNES, J. J., GREENHLATT, D. J. AND MILLER, L. G.: Benzodiazepine receptor binding of nonbenzodiazepines in vivo: Alpidem, zolpidem and zopidone. Brain Res. Bull. 29: 905-908, 1992.
14. COOPER, S. J. AND DESA, A.: Pyrazoloquinolines and zolpidem: Effects on hypertonic saline consumption in rehydrating rats. Drug Dev. Res. 14: 161-160, 1988.
15. DE LA GARZA, R. AND JOHANSON, C. E.: The discriminative stimulus properties of intragastrically administered d-amphetamine and pentobarbital in rhesus monkeys, J. Pharmacol. Exp. Ther. 243: 955-962, 1987.
16. 3H]zolpidem, J. Pharmacol. Exp. Ther 247: 309-322, 1988.
17. DEPOORTERE, H., ZIVKOVIC, B., LLOYD, K. D., SANGER, D. J., PERRAULT, G., LANGER, S. Z. AND BARTHOLINI, G.: Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects. J. Pharmacol. Exp. Ther. 237: 649-658, 1986.
18. DE WIT, H., BODKER, B. AND AMBRE, J.: Rate of increase in plasma drug levels influences subjective responses in humans. Paychopharmacology 107: 352-358, 1992.
19. DE WIT, H., PIERRI, J. AND JOHANSON, C. E.: Assessing pentobarbital preference in normal volunteers using a cumulative dosing procedure. Psychopharmacology 99: 416-421, 1989.
20. EVANS, S. M., FUNDERBURK, F. R. AND GRIFFITHS, R. R.: Zolpidem and triazolam in humans: Behavioral and subjective effects and abuse liability. J. Pharmacol. Exp. Ther. 255: 1246-1255, 1990.
21. EVANS, S. M. AND GRIFFITHS, R. R.: Dose-related caffeine discrimination in normal volunteers: Individual differences in subjective effects and self-reported cues. Behav. Pharmacol. 2: 345-356, 1991.
22. EVANS, S. M. AND JOHANSON, C. E.: Discriminative stimulus properties of histamine H1-antagonists in animals trained to discriminate d-amphetamine or pentobarbital. J. Pharmacol. Exp. Ther. 250: 779-787, 1989.
23. GRIFFITHS, R. R., BIGELOW, G. E. AND LIEBSON, I. A.: Differential effects of diazepam pentobarbital on mood and behavior. Arch. Gen. Psychiatry 40: 865-873, 1983.
24. GRIFFITHS, R. R. AND MUMFORD, G. K.: Caffeine: A drug of abuse? In Psychopharmacology: The Fourth Generation of Progress, ed. by F. E. Bloom and D. J. Kupfer, pp. 1699-1713, Raven Press, New York, NY 1995.
25. GRIFFITHS, R. R., SANNERUD, C., ATOR, N. A. AND BRADY, J. V.: Zolpidem behavioral pharmacology in baboons: Self-injection, discrimination, tolerance, and withdrawal, J. Pharmacol. Exp. Ther. 260: 1199-1208, 1992.
26. HEIHHMAN, S. J. AND HENNINOFIELD, J. E.: Discriminative stimulus effects of d-amphetamine, methylphenidate, and diazepam in humans. Psychopharmacology 103: 436-442, 1991.
27. HERLING, S., VALENTINO, R. J. AND WINGER, G. D.: Discriminative stimulus effects of pentobarbital in pigeons. Psychopharmacology 71: 21-28, 1980.
28. HERLING, S. AND WINGER, G.: Selective blockade of the discriminative stimulus effects of pentobarbital in pigeons. Psychopharmacology 75: 321-323, 1981.
29. JARBE, T. U. C.: Characteristics of pentobarbital discrimination in the gerbil: Transfer and antagonism. Psychopharmacology 49: 33-40, 1976.
30. JARBE, T. U. C., JOHANSSON, J. O. AND HENRIKSSON, B. G.: Delta-9-tetrahydrocannabinol and pentobarbital as discriminative cues in the mongolian gerbil (Meriones unguiculatus). Pharmacol. Biochem. Behav. 3: 403-410, 1975.
31. JARBE, T. U. C. AND OHLIN, G. C.: Discriminative effects of combination of delta-9-tetrahydro-cannabinol and pentobarbital in pigeons. Psychopharmacology 63: 233-239, 1979.
32. JASINSKI, D.: Assessment of the abuse potentiality of morphine-like drugs (methods used in man). In Drug Addiction I, ed. by W. R. Martin, pp. 197-258, Springer-Verlag, New York, NY, 1977.
33. JOHANSON, C. E.: Discriminative stimulus effects of diazepam in humans. J. Pharmacol. Exp. Ther. 257: 634-643, 1991a.
34. JOHANSON, C. E.: Further studies on the discriminative stimulus effects of diazepam in humans. Behav. Pharmacol. 2: 357-367, 1991b.
35. JOHANSSON, J. O. AND JARBE, T. U. C.: Antagonism of pentobarbital induced discrimination in the gerbil. Psychopharmacologia 41: 225-228, 1975.
36. KAMIEN, J. B., BICKEL, W. K., OLIVETO, A. H., SMITH, B. J., HIGGINS, S. T., HUGHES, J. R. AND BADGER, G. J.: Triazolam discrimination by humans under a novel response procedure: Effects of buspirone and lorazepam. Behav. Pharmacol. 5: 315-325, 1994.
37. KAMIEN, J. B., BICKEL, W. K., HUGHES, J. R., HIGGINS, S. T. AND SMITH, B. J.: Drug discrimination by humans compared to nonhuman: Current status and future directions. Psychopharmacology 111: 259-270, 1993.
38. KIRK, T., ROACHE, J. D. AND GRIFFITHS, R. R.: Dose-response evaluation of the amnestic effects of triazolam and pentobarbital in normal subjects. J. Clin. Psychopharmacol. 10: 160-167, 1990.
39. LAMB, R. J. AND HENNINGFIELD, J. E.: Human d-amphetamine drug discrimination: Methamphetamine and hydromorphone. J. Exp. Anal. Behav. 61: 169-180, 1994.
40. 1 - receptor selective imidazopyridine hypnotic zolpidem. Pharmacol. Biochem. Behav. 29: 781-783, 1988.
41. MARTIN, W. R., SLOAN, J. W., SAPIRO, J. D. AND JASINSKI D. R.: Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin. Pharmacol. Ther. 12: 245-258, 1971.
42. MASSEY, B. W. AND WOOLVERTON, W. L.: Discriminative stimulus effects of combinations of pentobarbital and ethanol in rhesus monkeys. Drug Alcohol Depend. 35: 37-43, 1994.
43. MCLEOD, D. R., GRIFFITHS, R. R., BIGELOW, G. E. AND YINGLING, J. E.: An automated version of the digit symbol substitution test (DSST). Behav. Res. Methods Instrum. 14: 463-466, 1982.
44. MUMFORD, G. K., ABREU, M. E. AND GRIFFITHS, R. R.: Cheating in human drug discrimination studies. In National Institute on Drug Abuse Research Monograph Series, Problems of Drug Dependence 1995: Proceedings of the 57th Annual Meeting, 162, ed. by L. S. Harris, pp. 274, U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Rockville, MD, 1996.
45. MUMFORD, G. K., RUSH, C. R. AND GRIFFITHS, R. R.: Abecarnil and alprazolam in humans: Behavioral, subjective and reinforcing effects. J. Pharmacol. Exp. Ther. 272: 570-580, 1995a.
46. MUMFORD, G. K., RUSH, C. R. AND GRIFFITHS, R. R.: A comparison of the abuse liability of alprazolam and DN-2327 (pazinaclone) in humans: Psychomotor, memory, subjective and reinforcing effects. Exp. Clin. Psychopharmacol 3: 39-48, 1995b.
47. NIERENBERG, J. AND ATOR, N. A.: Drug discrimination in rats successively trained to discriminate diazepam and pentobarbital. Pharmacol. Biochem. Behav. 35: 405-412, 1990.
48. OLIVETO, A. H., BICKEL, W. K., HUGHES, J. R., HIGGINS, S. T. AND FENWICK, J. W.: Triazolam as a discriminative stimulus in humans. Drug Alcohol Depend. 80: 133-142, 1992a.
49. OLIVETO, A. H., BICKEL, W. K., HUGHES, J. R., SHEA, P. J., HIGGINS, S. T. AND FENWICK, J. W.: Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports. J. Pharmacol. Exp. Ther. 261: 885-894, 1992b.
50. OLIVETO, A. H., BICKEL, W. K., KAMIEN, J. B., HUGHES, J. R. AND HIGGINS, S. T.: Effects of diazepam and hydromorphone in triazolam-trained humans under a novel-response drug discrimination procedure. Psychopharmacology 114: 417-423, 1994.
51. OLIVETO, A. H., ROSEN, M. I., WOODS, S. W. AND KOSTEN, T. R.: (1995). Discriminative stimulus, self-reported and cardiovascular effects of orally administered cocaine in humans, J. Pharmacol. Exp. Ther. 272: 231-241, 1995.
52. OVERTON, D. A., MERKLE, D. A. AND HAYES, M. L.: Are "no-drug" cues discriminated during drug-discrimination training? Animal Learn. Behav. 11: 295-301, 1983.
53. PERRAULT, G., MOREL, E., SANGER, D. J. AND ZIVKOVIC, B.: Differences in pharmacological profiles of a new generation of benzodiazepine and nonbenzodiazepine hypnotics. Eur. J. Pharmacol. 187: 487-494, 1990.
54. PRESTON, K. L. AND BIGELOW, G. E.: Subjective and discriminative effects of drugs, Behav. Pharmacol. 2: 293-313, 1991.
55. PRESTON, K. L. AND BIGELOW, G. E.: Drug discrimination assessment of agonist-antagonist opioids in humans: A three-choice saline-hydromorphone-butorphanol procedure. J. Pharmacol. Exp. Ther. 271: 48-60, 1994.
56. PRESTON, K. L., BIGELOW, G. E., BICKEL, W. K. AND LIEBSON, I. A.: Three-choice drug discrimination in opioid-dependent humans; hydromorphone, naloxpne and saline. J. Pharmacol. Exp. Ther. 243: 1002-1009, 1987.
57. PRESTON, K. L., BIGELOW, G. E., BICKEL, W. K. AND LIEBSON, I. A.: Drug discrimination in human postaddicts: Agonist-antagonist opioids. J. Pharmacol. Exp. Ther. 250: 184-196, 1989.
58. PRESTON, K. L., BIGELOW, G. E. AND LIEBSON, I. A.: Discrimination of butorpha- nol and nalbuphine in opioid-dependent humans. Pharmacol. Biochem. Behav. 37: 511-522, 1990.
59. REES, D. C. AND BALSTER, R. L.: Attenuation of the discriminative stimulus properties of ethanol and oxazepam, but not of pentobarbital, by Ro 15-4513 in mice. J. Pharmacol, Exp. Ther. 244: 592-598, 1988.
60. REES, D. C., KNISELY, J. S., BALSTER, R. L., JORDAN, S. AND BREEN, T. J.: Pentobarbital-like discriminative properties of halothane, 1,1,1-trichloroethane. isoamyl nitrite, flurothyl and oxazepam in mice. J. Pharmacol. Exp. Ther. 241: 507-515, 1987.
61. ROACHE, J. D. AND GRIFFITHS, R. R.: Comparison of triazolam and pentobarbital dose: Performance impairment, subjective effects and abuse liability. J. Pharmacol. Exp. Ther. 234: 978-988, 1985.
62. ROACHE, J. D. AND GRIFFITHS, R. R.: Lorazepam and meprobamate: dose effects in humans: Behavioral effects and abuse liability. J. Pharmacol. Exp. Ther. 243: 978-988, 1987a.
63. ROACHE, J. D. AND GRIFFITHS, R. R.: Interactions of diazepam and caffeine: Behavioral and subjective dose effects in humans. Pharmacol. Biochem. Behav. 26: 801-812, 1987b.
64. ROWLETT, J. K. AND WOOLVERTON, W. L.: Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: I, Comparison with triazolam in rhesus monkeys and rats. J. Pharmacol. Exp. Ther. 280: 162-173, 1997.
65. RUSH, C. R. AND GRIFFITHS, R. R.: Zolpidem, triazolam and temazepam: Behavioral and subject-rated effects in normal volunteers. J. Clin. Psychopharmacol. 16: 146-157, 1996.
66. RUSH, C. R., HIGGINS, S. T., BICKEL, W. K. AND HUGHES, J. R.: Acute effects of triazolam and lorazepam on human learning, performance, and subject ratings. J. Pharmacol. Exp. Ther. 264: 1218-1226, 1993a.
67. RUSH, C. R., HIGGINS, S. T., BICKEL, W. K. AND HUGHES, J. R.: A comparison of the acute behavioral effects of triazolam and temazepam in normals. Psychopharmacology 112: 407-414, 1993b.
68. RUSH, C. R., HIGGINS, S. T., BICKEL, W. K., WIEGNER, M. S. AND HUGHES, J. R.: Acute behavioral and cardiac effects of alcohol and caffeine, alone and in combination, in humans. Behav. Pharmacol. 4: 562-572, 1994c.
69. RUSH, C. R., HIGGINS, S. T., HUGHES, J. R. AND BICKEL, W. K.: Acute behavioral effects of triazolam, alone and in combination with caffeine, in humans. Exp. Clin. Psychopharmacol. 2: 211-222, 1994a.
70. RUSH, C. R., HIGGINS, S. T., HUGHES, J. R. AND BICKEL, W. K.: Acute behavioral effects of lorazepam, alone and in combination with caffeine, in humans. Behav. Pharmacol. 5: 245-254, 1994b.
71. RUSH, C. R., MADAKASIRA, S. AND GOLDMAN, N. H.: Acute behavioral effects of estazolam and triazolam in non-drug abusing volunteers. Exp. Clin. Psychopharmacol. 4: 300-307, 1996.
72. RUSH, C. R., SULLIVAN, J. AND GRIFFITHS, R. R.: Intravenous caffeine in stimulant drug abusera: Subjective reports and physiological effects. J. Pharmacol. Exp. Ther. 273: 351-358, 1995a.
73. RUSH, C. R., TROISI, J. R. I. I., CRITCHFIELD, T. S. AND GRIFFITHS, R. R.: Discriminative stimulus effects of diazepam and buspirone in normal volunteers. J. Exp. Anal. Behav. 63: 277-294, 1995b.
74. SANGER, D. J.: Further investigation of the stimulus properties of chlordiazepoxide and zolpidem. Agonism and antagonism by two novel benzodiazepines. Psychopharmacology 93: 365-368, 1, 987.
75. SANGER, D. J., JOLY, D. AND ZIVKOVIC, B.: Effects of zolpidem, a new imidazopy- ridine hypnotic, on the acquisition of conditioned fear in mice: Comparison with triazolam and CL 218,872. Psychopharmacology 90: 207-210, 1986.
76. SANGER, D. J., PERRAULT, G., MOREL, E., JOLY, D. AND ZIVKOVIC, B.: The behavioral profile of zolpidem, a novel hypnotic drug of imidazopyridine structure. Phyaiol. Behav. 41: 235-240, 1987.
77. SANGER, D. J. AND ZIVKOVIC, B.: The discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic. Psychopharmacology 89: 317-322, 1986.
78. SANGER, D. J. AND ZIVKOVIC, B.: Investigation of the development of tolerance to the actions of zolpidem and midazolam, Neuropharmacology 26: 1513-1518, 1987a.
79. SANGER, D. J. AND ZIVKOVIC, B.: Discriminative stimulus properties of chlordiazepoxide and zolpidem. Agonist and antagonist effects of CGS 9896 and ZK 91296. Neuropharmacology 26: 499-505, 1987b.
80. SANGER D. J. AND ZIVKOVIC B.: Further behavioural evidence for the selective sedative action of zolpidem. Neuropharmacology 27: 1125-1130, 1988.
81. SANNERUD, C. A. AND ATOR, N. A.: Drug discrimination analysis of midazolam under a three-lever procedure: I. Dose-dependent differences in gerneraliza- tion and antagonism. J. Pharmacol. Exp. Ther. 272: 100-111, 1995.
82. SAUVANET, J. P., LANGER, S. Z. AND MORSELLI, P. L.: Imidazopyridines in Sleep Disorders, Raven Press, New York, NY, 1988.
83. SCHMID, L., BOLLLAENDER, M., FUSEAU, C., FOURNIER, D., BROUILLET, E. AND MAZIERE, M.: Zolpidem displays heterogeneity in its binding to the nonhuman primate benzodiazepine receptor in vivo. J. Neurochem. 65: 1880-1886, 1995.
84. SCHUSTER, C. R., FISCHMAN, M. W. AND JOHANSON, C. E.: Internal stimulus control and subjective effects of drugs. In National Institute on Drug Abuse Research Monograph Series, Behavioral Pharmacology of Human Drug Dependence, 37, ed. by T. Thompson and C. E. Johanson, pp. 116-129, U.S. Department of Health and Human Services. National Institutes of Health, National Institute on Drug Abuse. Rockville, MD, 1981.
85. SCHUSTER, C. R. AND JOHANSON, C. E.: Relationship between the discriminative stimulus properties and subjective effects of drugs, In Transduction Mechanisms of Drug Stimuli, ed. by F. C. Colpaert and R. L. Balster, pp. 161-175, Springer-Verlag. Berlin. 1988.
86. WILLETTS, J., TOKARZ, M. E. AND BALSTER, R. L.: Pentobarbital-Like effects of N-methyl-D-aspartate antagonists in mice. Life Sci. 48: 1795-1798, 1991.
87. WINGER, G. AND HERLING, S.: Discriminative stimulus effects of pentobarbital in rhesus monkeys: Tests of stimulus generalization and duration of action. Psychopharmacology 76: 172-176, 1982.
88. YERBURY, R. E. AND COOPER, S. J.: Novel benzodiazepine receptor ligands: Palatable food intake following zolpidem, CGS 17867A, or Ro 23-0364, in the rat. Pharmacol. Biochem. Behav. 33: 303-307, 1989.